Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    19029902 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
2 Completed The Interaction Between Measles and DTP Vaccination
Conditions: Non-target Heterologous Effects of Vaccines;   Vaccine Interactions
Interventions: Biological: Measles Vaccine at 9 months of age;   Biological: Diphtheria-tetanus-whole cell pertussis vaccine at 9 months of age;   Biological: Measles Vaccine at 18 months of age
3 Completed Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda
Conditions: HIV;   Acquired Immunodeficiency Syndrome;   Influenza
Intervention: Drug: Seasonal trivalent inactivated influenza vaccine (Vaxigrip®)
4 Recruiting VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Condition: Immune System

Indicates status has not been verified in more than two years